Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues.
The company reported worldwide net revenues of $12.31 billion for the March quarter, up 1% from the corresponding period of 2023.
Net income, adjusted for special items, declined to $2.31 per share in Q1 from $2.46 per share in the year-ago quarter. On a reported basis, first-quarter profit was $1.37 billion or $0.77 per share, compared to $239 million $0.13 per share last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Can Nvidia match its stellar FY25 performance this year?
For Nvidia Corporation (NASDAQ: NVDA), fiscal 2025 was a pivotal year in which the GPU giant generated record-high revenue and profit, capitalizing on its leadership in the AI chip market.
What to expect when Hormel Foods (HRL) reports Q2 2025 earnings results
Shares of Hormel Foods Corporation (NYSE: HRL) stayed green on Tuesday. The stock has gained 6% in the past three months. The branded foods company is scheduled to report its earnings
HD Earnings: Key quarterly highlights from Home Depot’s Q1 2025 financial results
The Home Depot (NYSE: HD) reported its first quarter 2025 earnings results today. Sales of $39.9 billion were up 9.4% year-over-year. Comparable sales decreased 0.3%. Net earnings were $3.4 billion,
